ClinVar Miner

Submissions for variant NM_005373.3(MPL):c.1621C>T (p.Gln541Ter)

gnomAD frequency: 0.00004  dbSNP: rs369156948
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV001854660 SCV002217130 pathogenic Congenital amegakaryocytic thrombocytopenia; Essential thrombocythemia 2023-12-14 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Gln541*) in the MPL gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 95 amino acid(s) of the MPL protein. This variant is present in population databases (rs369156948, gnomAD 0.008%). This premature translational stop signal has been observed in individual(s) with autosomal recessive congenital amegakaryocytic thrombocytopenia (PMID: 19302922). ClinVar contains an entry for this variant (Variation ID: 134819). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This variant disrupts a region of the MPL protein in which other variant(s) (p.Lys553Argfs*77) have been determined to be pathogenic (PMID: 23625800; Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.
ITMI RCV000121532 SCV000085726 not provided not specified 2013-09-19 no assertion provided reference population

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.